Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods

Triple-negative breast cancer (TNBC) poses a significant challenge in terms of prognosis and disease recurrence. The limited treatment options and the development of resistance to chemotherapy make it particularly difficult to manage these patients. However, recent research has been shifting its foc...

Descripción completa

Detalles Bibliográficos
Autores principales: Porta, Francesca Maria, Sajjadi, Elham, Venetis, Konstantinos, Frascarelli, Chiara, Cursano, Giulia, Guerini-Rocco, Elena, Fusco, Nicola, Ivanova, Mariia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381494/
https://www.ncbi.nlm.nih.gov/pubmed/37511789
http://dx.doi.org/10.3390/jpm13071176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381494/
https://www.ncbi.nlm.nih.gov/pubmed/37511789
http://dx.doi.org/10.3390/jpm13071176

Ejemplares similares